These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

As an organization founded with an SBIR NIH/NCI grant to develop a patient-centric, AI-driven Deep Learning Clinical Trial ...

As an organization founded with an SBIR NIH/NCI grant to develop a patient-centric, AI-driven Deep Learning Clinical Trial Matching System (DLCTMS, also known as Synergy-AI), Massive Bio has ...

Both the SBIR and STTR programs are divided into three phases listed below. NIH has special Technical Assistance Programs to help small businesses move their technologies from the lab into the hands ...

Several people also said that even minor disruptions can be problematic because researchers typically run extremely lean operations and don't have spare money to cover any shortfalls. "We are already ...

ANT308 is a FIRST-IN-CLASS immunotherapeutic with broad therapeutic potential across hematologic malignancies and solid tumors with the potential to enhance response rates in cancers that are ...

Brookline Capital Markets initiated coverage on Marker Therapeutics (NASDAQ:MRKR), a company focused on developing T cell-based immunotherapies for cancer, with a Buy rating and a 12-to-18-month price ...

TAMPA, FLORIDA / ACCESS Newswire / February 4, 2025 / Health Hug, a pediatric digital health organization specializing in family-centered care management, has announced a groundbreaking partnership wi ...

This funding, along with a $2 million award from the NIH Small Business Innovation Research (SBIR) program, is expected to advance MT-601's clinical program, set to commence in 2025. These ...

NIH & NSF SBIR/STTR grants for MedTech (Part 2) Please find part 1 here: https://lnkd.in/g7NaZCA7 💡 Understanding the Key Differences Between SBIR and STTR Programs ️ Both the Small ...